Pfizer: new Covid vaccine approved by EU
(CercleFinance.com) - The European Commission has announced the approval of Comirnaty XBB.
1.5, developed by BioNTech-Pfizer.
This vaccine marks a new milestone in the fight against the disease. This is the third adaptation of this vaccine to respond to new variants of COVID-19.
The vaccine is licensed for use in adults, children and infants over 6 months of age.
This authorisation follows a rigorous assessment by the European Medicines Agency under its accelerated review mechanism.
Copyright (c) 2023 CercleFinance.com. All rights reserved.